Navigation Links
DX-88 for Hereditary Angioedema Meets Primary and Secondary,Endpoints in Phase 3 Trial (EDEMA3)

60760258

A replay of the webcast will be available through May 17, 2007 and may be accessed by dialing 1-888-286-8010. International callers should dial 617-801-6888. The replay passcode for all callers is 25344900. The webcast will be archived on the Dyax website for an indefinite period of time.

About Dyax

Dyax is focused on advancing novel biotherapeutics for unmet medical needs, with an emphasis on oncology and inflammatory indications. Dyax utilizes its proprietary drug discovery technology to identify antibody, small protein and peptide compounds for clinical development.

Dyax's lead product candidate is DX-88, a recombinant small protein that is currently in clinical trials for its therapeutic potential in two separate indications. Dyax has successfully completed three Phase 2 trials and a Phase 3 trial of DX-88 for the treatment of hereditary angioedema (HAE). A confirmatory study, known as EDEMA4, is planned and expected to begin in the first quarter of 2007. DX-88 has orphan drug designation in the U.S. and E.U., as well as Fast Track designation in the U.S. for the treatment of acute attacks of HAE.

Additionally, Dyax has successfully completed a Phase 1/2 trial of DX-88 for the prevention of blood loss during on-pump coronary artery bypass graft (CABG) procedures. Dyax is initiating a Phase 2 trial for further development of DX-88 in on-pump cardiothoracic surgery (CTS), including CABG and heart valve replacement or repair procedures.

Dyax identified DX-88 and other compounds in its pipeline using its patented phage display technology, which rapidly selects compounds that bind with high affinity and specificity to therapeutic targets. Dyax leverages this technology broadly with over 70 revenue-generating licenses and collaborations for therapeutic discovery, as well as in non-core areas such as affinity separations, diagnostic imaging, and research reagents.

Dyax is headquartered in Cambridge, Massachusett
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
2. Lev Pharmaceuticals Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
3. ENDEAVOR IV Clinical Trial Meets Primary Endpoint
4. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
5. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
6. Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint
7. Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
8. SciClone and Sigma-Tau Report Thymalfasin Meets Primary Endpoint in Phase 2 Malignant Melanoma Trial
9. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
10. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
11. Alexzas AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating Schizophrenic Patients With Acute Agitation
Post Your Comments:
(Date:7/31/2015)... PORTLAND, Ore., July 31, 2015  Semler Scientific, Inc. ... and testing services to healthcare insurers and physician groups, ... June 30, 2015. "In the second ... over year revenue growth of 54%, quarter over quarter ... of the installed base of FloChec® units of 18%," ...
(Date:7/31/2015)...  Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage ... of autoimmune diseases, asthma and allergic diseases, and cancer, ... to its board of directors. ... is a tremendous asset to our board," said ... of Xencor. "Xencor faces a range of opportunities for ...
(Date:7/31/2015)... India , July 31, 2015 ... CRM solutions for video, data and cloud computing ... with a leading pharma giant for Internet of ... different IoT applications offered on subscription model. ... Pharma giant is striving for business innovations ...
Breaking Medicine Technology:Semler Reports Second Quarter 2015 Financial Results 2Semler Reports Second Quarter 2015 Financial Results 3Semler Reports Second Quarter 2015 Financial Results 4Semler Reports Second Quarter 2015 Financial Results 5Semler Reports Second Quarter 2015 Financial Results 6Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... 4, 2010 Poniard Pharmaceuticals, Inc. (Nasdaq: ... therapies, today announced that it has been awarded $244,479 ... Qualifying Therapeutic Discovery Project (QTDP) program established under Section ... use the grant to advance the development of its ...
... Nov. 4, 2010 Eli Lilly and Company (NYSE: ... Officer John Lechleiter Ph.D. today presented an $11.6 million ... contributions of Lilly,s U.S. employees and retirees and a ... were raised for the Central Indiana chapter and other ...
Cached Medicine Technology:Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program 2Poniard Pharmaceuticals Awarded $244,479 Grant Under Qualifying Therapeutic Discovery Project Program 3Lilly Surpasses United Way 2010 Campaign Goal 2
(Date:7/31/2015)... ... July 31, 2015 , ... Jacksonville-based drug and ... True North Conference Center. The medical community, social workers, law enforcement, and government ... more aligned in the effort to better understand and combat sex trafficking. Lead ...
(Date:7/31/2015)... ... 31, 2015 , ... Coco Libre announced today that their flagship Organic Coconut ... 2015 Vans US Open of Surfing, July 25 through August 2 in Huntington Beach, ... on the market, is a natural choice given the Open’s commitment to sustainable practices. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... Those looking to catch a new and refreshing show on Broadway, look no ... and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille ...
(Date:7/31/2015)... ... 2015 , ... According to an article published July 2 on ... reach a consensus on the steps that need to be taken to successfully complete ... percent consensus on a series of steps that each surgeon must complete for each ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... on pharmaceutical negligence is now available online at ( http://www.lawline.com/cle/course/its-a-wonderful-life-if-you-receive-the-right-meds-a-discussion-of-pharmaceutical-negligence ). ... 94% approval rating from the nationwide audience. The course focused on ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2
... March 2 "President Obama,s appointment of Governor Kathleen ... is yet another clear signal that this is the ... a reality.Health care reform is crucial to fixing the ... Health and Human Services, we can be sure it ...
... donors to respond PHILADELPHIA, March 2 Today,s ... area. Many area blood drives were cancelled ... could not honor their appointments, resulting in a ... Cross, Penn-Jersey Region scheduled blood donations for the ...
... for Ultra-High Performance Liquid Chromatography (UHPLC) Applications; Company ... Mass., March 2 ESA Biosciences, Inc., a ... systems that improve results for pharmaceutical development and ... launch a new, ultra-high-performance version of its award-winning ...
... EVANSTON, Ill. --- Optical technology developed by a Northwestern ... be effective in detecting the presence of pancreatic cancer ... to clinical trial results published in the journal ... which researchers hope could help raise the extremely low ...
... researchers report that a naturally occurring compound found in ... respiratory inflammation that causes conditions like asthma, allergic rhinitis ... Published in the March edition of the journal ... chemical in broccoli, triggers an increase of antioxidant enzymes ...
... meets East as faculty, students and alumni from University ... journey to share their knowledge with peers on the ... taking place March 27 through April 14, includes a ... faculty member and editor-in-chief of University of the Rockies ...
Cached Medicine News:Health News:Kathleen Sebelius Ready to Lead Healthcare Reform in 2009 2Health News:Local Blood Donations Impacted by Today's Snow Storm 2Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 2Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 3Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 4Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 5Health News:Optical techniques show continued promise in detecting pancreatic cancer 2Health News:Optical techniques show continued promise in detecting pancreatic cancer 3Health News:Optical techniques show continued promise in detecting pancreatic cancer 4Health News:Broccoli may help protect against respiratory conditions like asthma 2Health News:University of the Rockies Faculty and Students Travel to China to Share Western Philosophy 2Health News:University of the Rockies Faculty and Students Travel to China to Share Western Philosophy 3
... especially designed to make your bariatric patients feel ... manage them. , ,When caring for this ... up in bed, turning, sitting, standing can ... Excel Care ES bed offers features to make ...
... of solutions for inhalation, USP, produced specifically ... for inhalation and sodium chloride inhalation solutions ... 500 and 1000mL sizes. Bottles are compatible ... be used alone for filling humidifiers and ...
... 2 1000ML Sterile H 2 O, ... ease of use. You can obtain heated and ... FIO 2 . We offer a wide selection ... sodium chloride inhalation, USP; and 0.9% sodium chloride ...
... O W/O Adapter., ... systems feature a dual-purpose reservoir with a snap-open ... attachment of a humidifier adapter. The oxygen pathway ... oxygen delivery tubing. An audible relief valve warns ...
Medicine Products: